| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |